INCY — INCYTE CORP
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying INCY?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 3 tracked investors who changed their INCY position last quarter, 1 bought and 2 sold (33% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 52/100 in a Squeeze regime).
- +1 tracked investor added or increased positions last quarter (Paul Tudor Jones)
- +6 tracked investors reported holding INCY at their latest filing
- −2 tracked investors reduced or exited last quarter (1 reduced, 1 sold out)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 8/4/2026.
About INCYTE CORP (INCY)
INCYTE CORP (INCY) appears in the most recent 13F filings of 6 tracked institutional investors. The largest disclosed position is held by Ray Dalio (Bridgewater Associates), valued at $32M. Across recent filings, tracked investors recorded 4 new positions, 2 increased, 2 reduced, and 1 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in INCY
How many top investors track INCY
Several tracked investors have exposure.
INCY Ownership Composition
How INCYTE CORP is held across tracked investor types, based on reported 13F positions.
- Other58.1%
- Hedge Funds23.1%
- Growth Funds18.8%
Tracked investors reporting INCY
- Ray DalioMar 31, 2026Bridgewater AssociatesShares130.3KValue$12.3M% Portfolio0.05%
- Ken GriffinMar 31, 2026Citadel AdvisorsShares135.7KValue$12.8M% Portfolio0.00%
- Steve CohenMar 31, 2026Point72 Asset ManagementShares176.3KValue$16.6M% Portfolio0.02%
- Izzy EnglanderMar 31, 2026Millennium ManagementShares172.9KValue$16.3M% Portfolio0.01%
- Cathie WoodDec 31, 2025ARK Investment ManagementShares137KValue$13.5M% Portfolio0.20%
- Paul Tudor JonesMar 31, 2026Tudor Investment CorpShares4.5KValue$423.4K% Portfolio0.00%
Recent activity
- $375.3KFeb 17, 2026
- $423.4KMay 15, 2026
- Reduced$12.3M(-60.35%)May 15, 2026
- Sold$0(-100.00%)May 12, 2026
- Increased$18.2M(60.92%)Feb 17, 2026
- Increased$32.5M(150.29%)Feb 13, 2026
- Reduced$13.5M(-7.05%)Feb 11, 2026
- New$11.1MNov 13, 2025
- New$12.5MNov 12, 2025
Frequently asked questions
- How many institutional investors hold INCY?
- 6 tracked institutional investors disclosed a position in INCY (INCYTE CORP) in their most recent 13F filing.
- Who is the largest institutional holder of INCY?
- Ray Dalio, Bridgewater Associates, holds the largest disclosed position in INCY, valued at $32M.
- Did institutional ownership of INCY increase or decrease?
- Across recent 13F filings, tracked investors recorded 4 new positions, 2 increased, 2 reduced, and 1 fully exited INCY.
- Where does this INCY ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.